查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1598546

全球婴儿临床营养市场 – 全球产业分析、规模、占有率、成长、趋势、预测 (2031)

Infant Clinical Nutrition Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031
出版日期: | 出版商: Fairfield Market Research | 英文 159 Pages | 商品交期: 2-5个工作天内

价格
简介目录

在 2024 年至 2031 年的预测期内，全球婴儿临床营养市场规模预计将以 6.1% 的复合年增长率扩大。在出生率上升、消费者意识提高和营养科学进步的推动下，2024 年市场价值预计将达到 275.3 亿美元，预计到 2031 年将达到 416.8 亿美元。

由于人们对婴儿健康需求的认识不断增强以及早产的普遍存在，对婴儿临床营养产品的需求正在上升。根据世界卫生组织 (WHO) 统计，每年有超过 1500 万早产儿出生，凸显了对营养补充剂的需求。因此，产品配方的创新，包括牛奶、大豆、有机和益生菌/益生元产品，正在推动市场成长。

世界出生率不断上升，特别是在发展中国家，这促使对婴儿营养产品的需求增加。各国政府和医疗机构正积极努力改善早产的预后，进一步提振市场。

本报告考察了全球婴儿临床营养市场，并提供了市场概况，包括按产品类型、给药途径、地区划分的趋势以及进入市场的公司的竞争趋势。

目录

第 1 章执行摘要

第二章市场概述

  • 市场定义与细分
  • 市场动态
  • 价值链分析
  • 波特五力分析
  • 新冠肺炎 (COVID-19) 影响分析
  • 乌克兰与俄罗斯衝突的影响
  • 经济概况
  • 杵分析

第 3 章2019-2031 年全球婴儿临床营养市场展望

  • 2019-2031 年全球婴儿临床营养市场展望（按产品类型、价值（十亿美元））
  • 2019-2031 年全球婴儿临床营养市场展望（按给药途径）、价值（十亿美元）
  • 2019-2031 年全球婴儿临床营养市场展望（按地区、价值（十亿美元））

第 4 章 2019-2031 年北美婴儿临床营养市场展望

第 5 章欧洲婴儿临床营养市场展望，2019-2031

第六章亚太地区婴儿临床营养市场展望，2019-2031

第 7 章拉丁美洲婴儿临床营养市场展望，2019-2031

第 8 章中东与非洲婴儿临床营养市场展望，2019-2031 年

第九章竞争态势

  • 依产品类型和给药途径划分的热图
  • 2024 年公司市占率分析
  • 竞争对手仪表板
  • 公司简介
    • Abbott Laboratories
    • Baxter International Inc.
    • Nestle S.A.
    • Danone
    • Meiji Holdings Co., Ltd.,
    • Fresenius SE & Co. KGaA
    • Reckitt Benckiser Group Plc
    • Perrigo Co. Plc
    • Ingredion Inc.
    • Solace Nutrition

第 10 章附录

简介目录

The global infant clinical nutrition market is projected to expand at a CAGR of 6.1% during the forecast period from 2024 to 2031. Valued at US$ 27.53 billion in 2024, the market is expected to reach US$ 41.68 billion by 2031, fueled by increasing birth rates, rising consumer awareness, and advancements in nutritional science.

The demand for infant clinical nutrition products is on the rise due to growing awareness of infant health needs and the prevalence of premature births. According to the World Health Organization (WHO), more than 15 million preterm babies are born annually, emphasizing the need for nutrition-rich supplements. As a result, innovations in product formulations, including milk-based, soy-based, organic, and probiotic/prebiotic products, are driving market growth.

Key Market Drivers

1.Increasing Birth Rates and Premature Births:

  • Global birth rates are rising, particularly in developing nations, creating an increased demand for infant nutritional products.
  • Governments and healthcare organizations are actively working to improve the outcomes of preterm births, further boosting the market.

2.Consumer Awareness and Lifestyle Changes:

  • With rising female labor force participation, dual-income households are increasingly investing in premium nutritional products for their infants.
  • Growing awareness about infant health needs and nutritional supplements is driving the demand for high-quality products.

3.Demand for Premium Products:

  • Parents are willing to spend more on premium-quality infant nutrition products due to improved purchasing power and heightened health consciousness.

4.Technological Advancements:

  • Continuous research in biotechnology is enabling manufacturers to develop specialized products that cater to diverse nutritional needs, improving metabolic and developmental outcomes.

Opportunities in the Market

1.Innovation in Product Development:

  • Manufacturers are focusing on developing advanced formulations, including organic and probiotic-based products, to meet specific infant needs.
  • Incorporation of cutting-edge technologies and neonatal care research is paving the way for more effective nutritional solutions.

2.Geographical Expansion:

  • Emerging markets in South Asia, East Asia, and Africa are becoming key areas of growth due to rising birth rates and increased awareness of infant health.

3.Strategic Investments:

  • Multinational players are heavily investing in research, branding, and supply chain optimization to strengthen their market position.

Challenges Facing the Market

Stringent regulations from authorities such as the U.S. Food and Drug Administration (FDA) and the European Food Safety Authority (EFSA) impose strict quality standards. Manufacturers must comply with nutrient specifications and labeling requirements, often resulting in prolonged approval procedures and higher production costs.

Regional Insights

North America:

  • North America is a prominent region in the infant clinical nutrition market, driven by advancements in food nutrition.
  • The increasing adoption of clean-label trends significantly contributes to the region's market growth.

Europe:

  • Europe plays a key role in the market, with a growing preference for premium-quality infant nutrition products.
  • Capital investments in the food sector and rising consumer awareness about nutritional supplements are major growth factors.

Asia-Pacific:

  • Asia-Pacific is emerging as the fastest-growing region in the infant clinical nutrition market.
  • Population growth and improvements in healthcare infrastructure are key drivers boosting market expansion in this region.

Competitive Analysis

The infant clinical nutrition market is highly competitive, with multinational players dominating the landscape. Companies are focusing on R&D, branding, and innovative product launches to attract new customers and retain existing ones.

Key Players Include:

  • Abbott Laboratories
  • Baxter International
  • Nestle S.A.
  • Danone
  • Meiji Holdings Co., Ltd.
  • Fresenius SE & Co. KGaA
  • Reckitt Benckiser Group Plc
  • Perrigo Co. Plc
  • Ingredion Inc.
  • Solace Nutrition

These companies are leveraging advanced technologies and efficient production processes to enhance product offerings and meet rising consumer demands.

Infant Clinical Nutrition Market Segmentation

1.By Product Type:

  • Milk-Based
  • Soy-Based
  • Organic
  • Probiotic/Prebiotic

2.By Route of Administration:

  • Oral Administration
  • Enteral Administration
  • Intravenous Administration

3.By Region:

  • North America
  • Latin America
  • Europe
  • South Asia & Pacific
  • East Asia
  • Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Infant Clinical Nutrition Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value, 2024
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. Porter's Five Forces Analysis
  • 2.5. COVID-19 Impact Analysis
    • 2.5.1. Supply
    • 2.5.2. Demand
  • 2.6. Impact of Ukraine-Russia Conflict
  • 2.7. Economic Overview
    • 2.7.1. World Economic Projections
  • 2.8. PESTLE Analysis

3. Global Infant Clinical Nutrition Market Outlook, 2019 - 2031

  • 3.1. Global Infant Clinical Nutrition Market Outlook, by Product Type, Value (US$ Bn), 2019 - 2031
    • 3.1.1. Key Highlights
      • 3.1.1.1. Milk-Based
      • 3.1.1.2. Soy-Based
      • 3.1.1.3. Organic
      • 3.1.1.4. Probiotic/Prebiotic
  • 3.2. Global Infant Clinical Nutrition Market Outlook, by Route of Administration, Value (US$ Bn), 2019 - 2031
    • 3.2.1. Key Highlights
      • 3.2.1.1. Oral administration
      • 3.2.1.2. Enteral administration
      • 3.2.1.3. Intravenous administration
  • 3.3. Global Infant Clinical Nutrition Market Outlook, by Region, Value (US$ Bn), 2019 - 2031
    • 3.3.1. Key Highlights
      • 3.3.1.1. North America
      • 3.3.1.2. Europe
      • 3.3.1.3. Asia Pacific
      • 3.3.1.4. Latin America
      • 3.3.1.5. Middle East & Africa

4. North America Infant Clinical Nutrition Market Outlook, 2019 - 2031

  • 4.1. North America Infant Clinical Nutrition Market Outlook, by Product Type, Value (US$ Bn), 2019 - 2031
    • 4.1.1. Key Highlights
      • 4.1.1.1. Milk-Based
      • 4.1.1.2. Soy-Based
      • 4.1.1.3. Organic
      • 4.1.1.4. Probiotic/Prebiotic
  • 4.2. North America Infant Clinical Nutrition Market Outlook, by Route of Administration, Value (US$ Bn), 2019 - 2031
    • 4.2.1. Key Highlights
      • 4.2.1.1. Oral administration
      • 4.2.1.2. Enteral administration
      • 4.2.1.3. Intravenous administration
    • 4.2.2. BPS Analysis/Market Attractiveness Analysis
  • 4.3. North America Infant Clinical Nutrition Market Outlook, by Country, Value (US$ Bn), 2019 - 2031
    • 4.3.1. Key Highlights
      • 4.3.1.1. U.S. Infant Clinical Nutrition Market by Product Type, Value (US$ Bn), 2019 - 2031
      • 4.3.1.2. U.S. Infant Clinical Nutrition Market by Route of Administration, Value (US$ Bn), 2019 - 2031
      • 4.3.1.3. Canada Infant Clinical Nutrition Market by Product Type, Value (US$ Bn), 2019 - 2031
      • 4.3.1.4. Canada Infant Clinical Nutrition Market by Route of Administration, Value (US$ Bn), 2019 - 2031
    • 4.3.2. BPS Analysis/Market Attractiveness Analysis

5. Europe Infant Clinical Nutrition Market Outlook, 2019 - 2031

  • 5.1. Europe Infant Clinical Nutrition Market Outlook, by Product Type, Value (US$ Bn), 2019 - 2031
    • 5.1.1. Key Highlights
      • 5.1.1.1. Milk-Based
      • 5.1.1.2. Soy-Based
      • 5.1.1.3. Organic
      • 5.1.1.4. Probiotic/Prebiotic
  • 5.2. Europe Infant Clinical Nutrition Market Outlook, by Route of Administration, Value (US$ Bn), 2019 - 2031
    • 5.2.1. Key Highlights
      • 5.2.1.1. Oral administration
      • 5.2.1.2. Enteral administration
      • 5.2.1.3. Intravenous administration
    • 5.2.2. BPS Analysis/Market Attractiveness Analysis
  • 5.3. Europe Infant Clinical Nutrition Market Outlook, by Country, Value (US$ Bn), 2019 - 2031
    • 5.3.1. Key Highlights
      • 5.3.1.1. Germany Infant Clinical Nutrition Market by Product Type, Value (US$ Bn), 2019 - 2031
      • 5.3.1.2. Germany Infant Clinical Nutrition Market by Route of Administration, Value (US$ Bn), 2019 - 2031
      • 5.3.1.3. U.K. Infant Clinical Nutrition Market by Product Type, Value (US$ Bn), 2019 - 2031
      • 5.3.1.4. U.K. Infant Clinical Nutrition Market by Route of Administration, Value (US$ Bn), 2019 - 2031
      • 5.3.1.5. France Infant Clinical Nutrition Market by Product Type, Value (US$ Bn), 2019 - 2031
      • 5.3.1.6. France Infant Clinical Nutrition Market by Route of Administration, Value (US$ Bn), 2019 - 2031
      • 5.3.1.7. Italy Infant Clinical Nutrition Market by Product Type, Value (US$ Bn), 2019 - 2031
      • 5.3.1.8. Italy Infant Clinical Nutrition Market by Route of Administration, Value (US$ Bn), 2019 - 2031
      • 5.3.1.9. Turkey Infant Clinical Nutrition Market by Product Type, Value (US$ Bn), 2019 - 2031
      • 5.3.1.10. Turkey Infant Clinical Nutrition Market by Route of Administration, Value (US$ Bn), 2019 - 2031
      • 5.3.1.11. Russia Infant Clinical Nutrition Market by Product Type, Value (US$ Bn), 2019 - 2031
      • 5.3.1.12. Russia Infant Clinical Nutrition Market by Route of Administration, Value (US$ Bn), 2019 - 2031
      • 5.3.1.13. Rest of Europe Infant Clinical Nutrition Market by Product Type, Value (US$ Bn), 2019 - 2031
      • 5.3.1.14. Rest of Europe Infant Clinical Nutrition Market by Route of Administration, Value (US$ Bn), 2019 - 2031
    • 5.3.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Infant Clinical Nutrition Market Outlook, 2019 - 2031

  • 6.1. Asia Pacific Infant Clinical Nutrition Market Outlook, by Product Type, Value (US$ Bn), 2019 - 2031
    • 6.1.1. Key Highlights
      • 6.1.1.1. Milk-Based
      • 6.1.1.2. Soy-Based
      • 6.1.1.3. Organic
      • 6.1.1.4. Probiotic/Prebiotic
  • 6.2. Asia Pacific Infant Clinical Nutrition Market Outlook, by Route of Administration, Value (US$ Bn), 2019 - 2031
    • 6.2.1. Key Highlights
      • 6.2.1.1. Oral administration
      • 6.2.1.2. Enteral administration
      • 6.2.1.3. Intravenous administration
    • 6.2.2. Others BPS Analysis/Market Attractiveness Analysis
  • 6.3. Asia Pacific Infant Clinical Nutrition Market Outlook, by Country, Value (US$ Bn), 2019 - 2031
    • 6.3.1. Key Highlights
      • 6.3.1.1. China Infant Clinical Nutrition Market by Product Type, Value (US$ Bn), 2019 - 2031
      • 6.3.1.2. China Infant Clinical Nutrition Market by Route of Administration, Value (US$ Bn), 2019 - 2031
      • 6.3.1.3. Japan Infant Clinical Nutrition Market by Product Type, Value (US$ Bn), 2019 - 2031
      • 6.3.1.4. Japan Infant Clinical Nutrition Market by Route of Administration, Value (US$ Bn), 2019 - 2031
      • 6.3.1.5. South Korea Infant Clinical Nutrition Market by Product Type, Value (US$ Bn), 2019 - 2031
      • 6.3.1.6. South Korea Infant Clinical Nutrition Market by Route of Administration, Value (US$ Bn), 2019 - 2031
      • 6.3.1.7. India Infant Clinical Nutrition Market by Product Type, Value (US$ Bn), 2019 - 2031
      • 6.3.1.8. India Infant Clinical Nutrition Market by Route of Administration, Value (US$ Bn), 2019 - 2031
      • 6.3.1.9. Southeast Asia Infant Clinical Nutrition Market by Product Type, Value (US$ Bn), 2019 - 2031
      • 6.3.1.10. Southeast Asia Infant Clinical Nutrition Market by Route of Administration, Value (US$ Bn), 2019 - 2031
      • 6.3.1.11. Rest of Asia Pacific Infant Clinical Nutrition Market by Product Type, Value (US$ Bn), 2019 - 2031
      • 6.3.1.12. Rest of Asia Pacific Infant Clinical Nutrition Market by Route of Administration, Value (US$ Bn), 2019 - 2031
    • 6.3.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America Infant Clinical Nutrition Market Outlook, 2019 - 2031

  • 7.1. Latin America Infant Clinical Nutrition Market Outlook, by Product Type, Value (US$ Bn), 2019 - 2031
    • 7.1.1. Key Highlights
      • 7.1.1.1. Milk-Based
      • 7.1.1.2. Soy-Based
      • 7.1.1.3. Organic
      • 7.1.1.4. Probiotic/Prebiotic
  • 7.2. Latin America Infant Clinical Nutrition Market Outlook, by Route of Administration, Value (US$ Bn), 2019 - 2031
    • 7.2.1. Key Highlights
      • 7.2.1.1. Oral administration
      • 7.2.1.2. Enteral administration
      • 7.2.1.3. Intravenous administration
    • 7.2.2. BPS Analysis/Market Attractiveness Analysis
  • 7.3. Latin America Infant Clinical Nutrition Market Outlook, by Country, Value (US$ Bn), 2019 - 2031
    • 7.3.1. Key Highlights
      • 7.3.1.1. Brazil Infant Clinical Nutrition Market by Product Type, Value (US$ Bn), 2019 - 2031
      • 7.3.1.2. Brazil Infant Clinical Nutrition Market by Route of Administration, Value (US$ Bn), 2019 - 2031
      • 7.3.1.3. Mexico Infant Clinical Nutrition Market by Product Type, Value (US$ Bn), 2019 - 2031
      • 7.3.1.4. Mexico Infant Clinical Nutrition Market by Route of Administration, Value (US$ Bn), 2019 - 2031
      • 7.3.1.5. Argentina Infant Clinical Nutrition Market by Product Type, Value (US$ Bn), 2019 - 2031
      • 7.3.1.6. Argentina Infant Clinical Nutrition Market by Route of Administration, Value (US$ Bn), 2019 - 2031
      • 7.3.1.7. Rest of Latin America Infant Clinical Nutrition Market by Product Type, Value (US$ Bn), 2019 - 2031
      • 7.3.1.8. Rest of Latin America Infant Clinical Nutrition Market by Route of Administration, Value (US$ Bn), 2019 - 2031
    • 7.3.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Infant Clinical Nutrition Market Outlook, 2019 - 2031

  • 8.1. Middle East & Africa Infant Clinical Nutrition Market Outlook, by Product Type, Value (US$ Bn), 2019 - 2031
    • 8.1.1. Key Highlights
      • 8.1.1.1. Milk-Based
      • 8.1.1.2. Soy-Based
      • 8.1.1.3. Organic
      • 8.1.1.4. Probiotic/Prebiotic
  • 8.2. Middle East & Africa Infant Clinical Nutrition Market Outlook, by Route of Administration, Value (US$ Bn), 2019 - 2031
    • 8.2.1. Key Highlights
      • 8.2.1.1. Oral administration
      • 8.2.1.2. Enteral administration
      • 8.2.1.3. Intravenous administration
    • 8.2.2. BPS Analysis/Market Attractiveness Analysis
  • 8.3. Middle East & Africa Infant Clinical Nutrition Market Outlook, by Country, Value (US$ Bn), 2019 - 2031
    • 8.3.1. Key Highlights
      • 8.3.1.1. GCC Infant Clinical Nutrition Market by Product Type, Value (US$ Bn), 2019 - 2031
      • 8.3.1.2. GCC Infant Clinical Nutrition Market by Route of Administration, Value (US$ Bn), 2019 - 2031
      • 8.3.1.3. South Africa Infant Clinical Nutrition Market by Product Type, Value (US$ Bn), 2019 - 2031
      • 8.3.1.4. South Africa Infant Clinical Nutrition Market by Route of Administration, Value (US$ Bn), 2019 - 2031
      • 8.3.1.5. Egypt Infant Clinical Nutrition Market by Product Type, Value (US$ Bn), 2019 - 2031
      • 8.3.1.6. Egypt Infant Clinical Nutrition Market by Route of Administration, Value (US$ Bn), 2019 - 2031
      • 8.3.1.7. Nigeria Infant Clinical Nutrition Market by Product Type, Value (US$ Bn), 2019 - 2031
      • 8.3.1.8. Nigeria Infant Clinical Nutrition Market by Route of Administration, Value (US$ Bn), 2019 - 2031
      • 8.3.1.9. Rest of Middle East & Africa Infant Clinical Nutrition Market by Product Type, Value (US$ Bn), 2019 - 2031
      • 8.3.1.10. Rest of Middle East & Africa Infant Clinical Nutrition Market by Route of Administration, Value (US$ Bn), 2019 - 2031
    • 8.3.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

  • 9.1. Product Type vs by Route of Administration Heatmap
  • 9.2. Company Market Share Analysis, 2024
  • 9.3. Competitive Dashboard
  • 9.4. Company Profiles
    • 9.4.1. Abbott Laboratories
      • 9.4.1.1. Company Overview
      • 9.4.1.2. Product Portfolio
      • 9.4.1.3. Financial Overview
      • 9.4.1.4. Business Strategies and Development
    • 9.4.2. Baxter International Inc.
      • 9.4.2.1. Company Overview
      • 9.4.2.2. Product Portfolio
      • 9.4.2.3. Financial Overview
      • 9.4.2.4. Business Strategies and Development
    • 9.4.3. Nestle S.A.
      • 9.4.3.1. Company Overview
      • 9.4.3.2. Product Portfolio
      • 9.4.3.3. Financial Overview
      • 9.4.3.4. Business Strategies and Development
    • 9.4.4. Danone
      • 9.4.4.1. Company Overview
      • 9.4.4.2. Product Portfolio
      • 9.4.4.3. Financial Overview
      • 9.4.4.4. Business Strategies and Development
    • 9.4.5. Meiji Holdings Co., Ltd.,
      • 9.4.5.1. Company Overview
      • 9.4.5.2. Product Portfolio
      • 9.4.5.3. Financial Overview
      • 9.4.5.4. Business Strategies and Development
    • 9.4.6. Fresenius SE & Co. KGaA
      • 9.4.6.1. Company Overview
      • 9.4.6.2. Product Portfolio
      • 9.4.6.3. Financial Overview
      • 9.4.6.4. Business Strategies and Development
    • 9.4.7. Reckitt Benckiser Group Plc
      • 9.4.7.1. Company Overview
      • 9.4.7.2. Product Portfolio
      • 9.4.7.3. Financial Overview
      • 9.4.7.4. Business Strategies and Development
    • 9.4.8. Perrigo Co. Plc
      • 9.4.8.1. Company Overview
      • 9.4.8.2. Product Portfolio
      • 9.4.8.3. Financial Overview
      • 9.4.8.4. Business Strategies and Development
    • 9.4.9. Ingredion Inc.
      • 9.4.9.1. Company Overview
      • 9.4.9.2. Product Portfolio
      • 9.4.9.3. Financial Overview
      • 9.4.9.4. Business Strategies and Development
    • 9.4.10. Solace Nutrition
      • 9.4.10.1. Company Overview
      • 9.4.10.2. Product Portfolio
      • 9.4.10.3. Financial Overview
      • 9.4.10.4. Business Strategies and Development

10. Appendix

  • 10.1. Research Methodology
  • 10.2. Report Assumptions
  • 10.3. Acronyms and Abbreviations